Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain
The aim of the study was to assess the budgetary impact of funding smoking-cessation drugs in COPD patients in Spain. A hybrid model (cohort and Markov) was developed for a 5-year time horizon. Only approved cessation drugs (varenicline, bupropion, and nicotine replacement therapy) were considered....
Main Authors: | Jiménez-Ruiz, Carlos A, Solano-Reina, Segismundo, Signes-Costa, Jaime, de Higes-Martinez, Eva, Granda-Orive, José I, Lorza-Blasco, José J, Riesco-Miranda, Juan A, Altet-Gomez, Neus, Barrueco, Miguel, Oyagüez, Itziar, Rejas, Javier |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590338/ |
Similar Items
-
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
by: Martinez-Raga, Jose, et al.
Published: (2012) -
Factors associated with smoking among tuberculosis patients in Spain
by: Jiménez-Fuentes, María Ángeles, et al.
Published: (2016) -
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
by: Rodríguez González-Moro, Jose Miguel, et al.
Published: (2015) -
Budgetary reforms
by: Pamela, Edwards, et al.
Published: (2005) -
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
by: Gros, Blanca, et al.
Published: (2015)